--- schema_version: "secwatch.filing_event.v1" accession: "0001140361-23-053522" form_type: "8-K" ticker: "ANGO" cik: "0001275187" company_name: "ANGIODYNAMICS INC" filed_at: "2023-11-16T23:59:59+00:00" generated_at: "2026-06-08T00:55:21.919753+00:00" event_type: "other" sentiment: "neutral" materiality_score: 0.3 calibrated_materiality_score: 0.3 confidence: "high" source: SEC EDGAR --- # AngioDynamics shareholders approve amended equity plan and elect directors at annual meeting ## Summary - All four board nominees elected with votes ranging from 23.6M to 25.9M for; avg 24.7M for, 1.9M withheld. - Amended 2020 Equity Incentive Plan approved with 24.1M for and 2.5M against (excl. 5.8M broker non-votes). - Advisory say-on-pay approved with 24.4M for, 2.2M against; annual frequency vote also passed. - Ratification of Deloitte & Touche as auditor for FY ending May 31, 2024: 32.4M for, 11K against. - Company will hold advisory say-on-pay votes annually until next required frequency vote. ## SEC filing metadata - accession: 0001140361-23-053522 - form_type: 8-K - ticker: ANGO - cik: 0001275187 - company_name: ANGIODYNAMICS INC - filed_at: 2023-11-16T23:59:59+00:00 - event_type: other - sentiment: neutral - materiality_score: 0.3 - calibrated_materiality_score: 0.3 - confidence: high - sec_items: 5.02, 5.07, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1275187/000114036123053522/0001140361-23-053522-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1275187/000114036123053522/ef20014806_8k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001140361-23-053522 - JSON: https://secwatch.observer/filing/0001140361-23-053522.json - Plain text: https://secwatch.observer/filing/0001140361-23-053522.txt ## Key facts - Shareholder Votes ANGIODYNAMICS INC shareholders approved Election of Class II directors at the 2023-11-14 meeting. - Proposal: director election - Outcome: passed - Meeting: 2023-11-14 source text: 1. The nominees for election to the Board of Directors of AngioDynamics were elected, each as a Class II director to serve until the 2026 Annual Meeting of Shareholders of AngioDynamics and until their respective successors are duly elected and qualified, based upon the following votes: Nominee Votes For Withheld Broker Non-Votes Eileen O. Auen 23,553,074 3,039,968 5,784,837 James C. Clemmer 25,883,397 709,645 5,784,837 Howard W. Donnelly 24,605,006 1,988,036 5,784,837 Jan Stern Reed 24,900,465 1,692,577 5,784,837 evidence_url: https://www.sec.gov/Archives/edgar/data/1275187/000114036123053522/0001140361-23-053522-index.htm - Shareholder Votes ANGIODYNAMICS INC shareholders approved Advisory approval of executive compensation (Say On Pay) at the 2023-11-14 meeting. - Proposal: say on pay - Outcome: passed - Meeting: 2023-11-14 source text: 3. The proposal to approve, on an advisory basis, AngioDynamics’ executive compensation of its named executive officers (“Say On Pay”) was approved based upon the following votes: Votes for approval 24,393,365 Votes against 2,193,446 Abstentions 6,231 Broker non-votes 5,784,837 evidence_url: https://www.sec.gov/Archives/edgar/data/1275187/000114036123053522/0001140361-23-053522-index.htm - Shareholder Votes ANGIODYNAMICS INC shareholders approved Approve amendments to the AngioDynamics, Inc. 2020 Equity Incentive Plan at the 2023-11-14 meeting. - Proposal: equity plan - Outcome: passed - Meeting: 2023-11-14 source text: 4. The proposal to approve amendments to the AngioDynamics, Inc. 2020 Equity Incentive Plan was approved based upon the following votes: Votes for approval 24,111,357 Votes against 2,461,478 Abstentions 20,207 Broker non-votes 5,784,837 evidence_url: https://www.sec.gov/Archives/edgar/data/1275187/000114036123053522/0001140361-23-053522-index.htm - Shareholder Votes ANGIODYNAMICS INC shareholders approved Advisory vote on frequency of Say On Pay vote at the 2023-11-14 meeting. - Proposal: say on pay frequency - Outcome: passed - Meeting: 2023-11-14 source text: 5. The proposal to approve, on an advisory basis the frequency of the Say On Pay vote was approved to take place annually based upon the following votes: Votes for 1 year 24,882,516 Votes for 2 years 5,024 Votes for 3 years 1,696,442 Abstentions 9,060 Broker non-votes 5,784,837 evidence_url: https://www.sec.gov/Archives/edgar/data/1275187/000114036123053522/0001140361-23-053522-index.htm - Shareholder Votes ANGIODYNAMICS INC shareholders approved Ratify appointment of Deloitte & Touche LLP as independent registered public accounting firm at the 2023-11-14 meeting. - Proposal: auditor ratification - Outcome: passed - Meeting: 2023-11-14 source text: 2. The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics’ independent registered public accounting firm for the fiscal year ending May 31, 2024 was approved based upon the following votes: Votes for approval 32,364,352 Votes against 11,237 Abstentions 2,290 There were no broker non-votes for this item. evidence_url: https://www.sec.gov/Archives/edgar/data/1275187/000114036123053522/0001140361-23-053522-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.